市場調査レポート
商品コード
1056752

在宅輸液療法の市場動向・市場シェア・市場規模の予測 (2022-2030年):製品 (輸液ポンプ・ニードルレスコネクター)・用途 (抗感染薬・化学療法)・地域別

Home Infusion Therapy Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-infective, Chemotherapy), By Region, And Segment Forecasts, 2022 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
在宅輸液療法の市場動向・市場シェア・市場規模の予測 (2022-2030年):製品 (輸液ポンプ・ニードルレスコネクター)・用途 (抗感染薬・化学療法)・地域別
出版日: 2022年01月17日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の在宅輸液療法の市場規模は、予測期間中7.9%のCAGRで推移し、2030年には617億米ドルの規模に成長すると予測されています。

心血管疾患 (CVD) 、癌、糖尿病などの生命を脅かす慢性疾患の罹患率の上昇が市場の成長に大きな影響を与えると予測されています。WHOの報告書によると、2019年の米国における総死亡者数の60.0%、疾病負担率の43.0%を上記の疾患が占めています。これにより、患者に薬を投与しながら、グルタミン、リン脂質、グルコース、アミノ酸などを含む栄養剤を注入する必要性が生じ、同地域の市場成長を後押しすると考えられています。

当レポートでは、世界の在宅輸液療法の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、製品パイプラインの分析、市場規模の推移・予測、製品・用途・地域/主要国など各種区分別の内訳、競合環境、市場シェア、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 在宅輸液療法市場の可変因子・動向・展望

  • 市場系統の見通し
  • 普及・成長の見通しマッピング
  • 製品パイプライン分析:用途別
  • 市場力学
  • 在宅輸液療法:市場分析ツール

第4章 在宅輸液療法市場:製品別

  • 定義・範囲
  • 市場シェア分析
  • セグメントダッシュボード
  • 世界の在宅輸液療法市場:製品別
  • 市場規模の予測・動向分析
    • 輸液ポンプ
    • 静脈内セット
    • IVカニューレ
    • ニードルレスコネクター

第5章 在宅輸液療法市場:用途別

  • 定義・範囲
  • 市場シェア分析
  • セグメントダッシュボード
  • 世界の在宅輸液療法市場:用途別
  • 市場規模の予測・動向分析
    • 抗感染薬
    • 内分泌
    • 水分補給
    • 化学療法
    • 経腸栄養
    • 非経口栄養
    • 特殊医薬品
    • その他

第6章 在宅輸液療法市場:地域・製品別

  • 定義と範囲
  • 市場シェア分析
  • ダッシュボード
  • スナップショット
  • 市場シェア
  • 市場規模の予測・動向分析
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第7章 在宅輸液療法市場:競合分析

  • 主要企業のプロファイル
    • Caesarea Medical Electronics
    • CareFusion Corporation
    • Baxter
    • B. Braun Melsungen AG
    • Fresenius Kabi
    • ICU Medical, Inc.
    • JMS Co. Ltd.
    • Smiths Medical
    • Terumo Corporation
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Home Infusion Therapy Market, By Region 2017 - 2030 (USD Million)
  • Table 4 Global Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 5 Global Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 6 North America Home Infusion Therapy Market, By Country, 2017 - 2030 (USD Million)
  • Table 7 North America Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 8 North America Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 9 U.S. Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 10 U.S. Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 11 Canada Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 12 Canada Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 13 Europe Home Infusion Therapy Market, By Country, 2017 - 2030 (USD Million)
  • Table 14 Europe Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 15 Europe Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 16 U.K. Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 17 U.K. Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 18 Germany Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 19 Germany Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 20 France Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 21 France Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 22 Italy Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 23 Italy Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 24 Spain Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 25 Spain Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 26 Netherlands Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 27 Netherlands Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 28 Belgium Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 29 Belgium Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 30 Switzerland Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 31 Switzerland Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 32 Russia Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 33 Russia Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 34 Sweden Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 35 Sweden Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 36 Asia Pacific Home Infusion Therapy Market, By Country, 2017 - 2030 (USD Million)
  • Table 37 Asia Pacific Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 38 Asia Pacific Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 39 India Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 40 India Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 41 Japan Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 42 Japan Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 43 China Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 44 China Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 45 Australia Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 46 Australia Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 47 South Korea Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 48 South Korea Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 49 Malaysia Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 50 Malaysia Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 51 Indonesia Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 52 Indonesia Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 53 Singapore Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 54 Singapore Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 55 Philippines Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 56 Philippines Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 57 Thailand Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 58 Thailand Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 59 Latin America Home Infusion Therapy Market, By Country, 2017 - 2030 (USD Million)
  • Table 60 Latin America Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 61 Latin America Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 62 Brazil Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 63 Brazil Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 64 Mexico Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 65 Mexico Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 66 Argentina Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 67 Argentina Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 68 Colombia Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 69 Colombia Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 70 Chile Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 71 Chile Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 72 MEA Home Infusion Therapy Market, By Country, 2017 - 2030 (USD Million)
  • Table 73 MEA Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 74 MEA Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 75 South Africa Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 76 South Africa Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 77 Saudi Arabia Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 78 Saudi Arabia Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 79 UAE Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 80 UAE Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 81 Israel Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 82 Israel Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)
  • Table 83 Egypt Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
  • Table 84 Egypt Home Infusion Therapy Market, By Application, 2017 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Home Infusion Therapy Market: Market snapshot
  • Fig. 8 Home Infusion Therapy Market: Market segmentation
  • Fig. 9 Home Infusion Therapy Market Strategy framework
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Home Infusion Therapy Market driver impact
  • Fig. 13 Home Infusion Therapy Market restraint impact
  • Fig. 14 Home Infusion Therapy Market Porter's Five Forces Analysis
  • Fig. 15 Home Infusion Therapy Market PESTEL analysis
  • Fig. 16 Home Infusion Therapy Market segment dashboard
  • Fig. 17 Home Infusion Therapy Market: Product Movement Analysis
  • Fig. 18 Infusion pumps estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 19 Intravenous Sets estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 20 IV cannulas estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 21 Needleless connectors estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 22 Home Infusion Therapy Market segment dashboard
  • Fig. 23 Home Infusion Therapy Market: Application Movement Analysis
  • Fig. 24 Anti-Infective market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 25 Endocrinology market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 26 Hydration Therapy market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 27 Chemotherapy market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 28 Enteral Nutrition market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 29 Parenteral Nutrition market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 30 Specialty Pharmaceuticals market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 32 Global Home Infusion Therapy Market: Regional movement analysis
  • Fig. 33 Global Home Infusion Therapy Market: Regional outlook and key takeaways
  • Fig. 34 Global market share, by region
  • Fig. 35 North America market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 36 U.S. market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 37 Canada market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 38 Europe market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 39 U.K. market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 40 Germany market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 41 France market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 42 Italy market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 43 Spain market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 44 Netherlands market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 45 Belgium market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 46 Switzerland market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 47 Russia market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 48 Sweden market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 49 Asia Pacific market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 50 China market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 51 Japan market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 52 India market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 53 Australia market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 54 South Korea market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 55 Malaysia market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 56 Indonesia market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 57 Singapore market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 58 Philippines market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 59 Thailand market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 60 Latin America market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 61 Brazil market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 62 Mexico market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 63 Argentina market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 64 Colombia market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 65 Chile market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 66 Middle East and Africa. market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 67 South Africa market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 68 Saudi Arabia market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 69 UAE market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 70 Israel market estimates and forecast, 2017 - 2030 (USD Million)
  • Fig. 71 Egypt market estimates and forecast, 2017 - 2030 (USD Million)
目次
Product Code: 978-1-68038-389-8

Home Infusion Therapy Market Growth & Trends:

The global home infusion therapy market size is expected to reach USD 61.7 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.9% from 2022 to 2030. Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biologicals to an individual at home. Favorable government policies and regulations are expected to propel market growth. In February 2018, the Bipartisan Budget Act of 2018 was signed into a law that states that all temporary payments of home infusion therapy in the U.S. will be covered by the government in accordance with this regulation.

In addition, the rising prevalence of chronic diseases, such as cardiovascular diseases (CVDs), cancer, diabetes, and other life-threatening conditions, is expected to have a high impact on the market growth. According to a WHO report, the above-mentioned diseases accounted for 60.0% of the total deaths and 43.0% of the disease burden in the U.S. in 2019. This creates the need to infuse nutritional products that contain glutamine, phospholipids, glucose, and amino acids while administering medication to patients, which, in turn, is expected to boost the market growth in this region.

The ongoing COVID-19 pandemic is expected to create lucrative opportunities for the market. Due to the restrictions caused by COVID-19, patients are waiting to seek treatment until they feel safe. Moreover, patients who seek infusion therapy already have diseases, which eventually weaken their immune systems. In such cases, going outside even to receive treatment becomes a potential threat. Reduced operating hours have led to difficulty in scheduling appointments as well, even if patients choose to continue treatment. Hence, home infusion therapy is expected to play a key role in supporting patients.

Home Infusion Therapy Market Report Highlights:

  • By product, infusion pump emerged as the largest segment in 2021 owing to the increasing use of delivery fluids such as nutrients and medications
  • The anti-infective application segment dominated the market in 2021 as a large number of procedures are performed during the administration of medications, such as antibiotics and antifungals
  • North America dominated the global market in 2021 owing to the increasing demand for new technologies, along with advanced healthcare infrastructure
  • The Asia Pacific market is projected to witness the fastest growth over the forecast period owing to the increasing number of diabetic patients in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1: Understanding the market dynamics
    • 1.9.2. Objective 2: Understanding the market estimates and forecasts
    • 1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
    • 1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Home Infusion Therapy Market Variables, Trends & Scope

  • 3.1. Market Lineage outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Product Pipeline Analysis, by Application
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
      • 3.4.1.1. Increasing geriatric population
      • 3.4.1.2. Rising prevalence of chronic diseases
      • 3.4.1.3. Recent technological advancements in infusion pumps
      • 3.4.1.4. Home healthcare as a cost-effective alternative
      • 3.4.1.5. Improving healthcare infrastructure in emerging economies
    • 3.4.2. Market Restraint Analysis
      • 3.4.2.1. Product recall
      • 3.4.2.2. Presence of complicated reimbursement framework and reimbursement cuts
    • 3.4.3. Industry Challenges
      • 3.4.3.1. Rising cost of home infusion therapy
  • 3.5. Home Infusion Therapy: Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier Power
      • 3.5.1.2. Buyer Power
      • 3.5.1.3. Substitution Threat
      • 3.5.1.4. Threat from new entrants
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political Landscape
      • 3.5.2.2. Environmental Landscape
      • 3.5.2.3. Social Landscape
      • 3.5.2.4. Technology Landscape
      • 3.5.2.5. Legal Landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis

Chapter 4. Home Infusion Therapy Market: Segment Analysis, by Product, 2017 - 2030 (USD Million)

  • 4.1. Definitions & Scope
  • 4.2. Product market share analysis, 2021 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Home Infusion Therapy Market, by Product, 2017 to 2030
  • 4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
    • 4.5.1. Infusion pumps
      • 4.5.1.1. Elastomeric
      • 4.5.2.1 Electrochemical
      • 4.5.2.2 Gravity
      • 4.5.2.3 Others
    • 4.5.2. Intravenous Sets
    • 4.5.3. IV cannulas
    • 4.5.4. Needleless connectors

Chapter 5. Home Infusion Therapy Market: Segment Analysis, By Application, 2017 - 2030 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. Application market share analysis, 2021 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Home Infusion Therapy Market, By Application, 2017 to 2030
  • 5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
    • 5.5.1. Anti-infective
    • 5.5.2. Endocrinology
      • 5.5.2.1 Diabetes
      • 5.5.2.2 Others
    • 5.5.3. Hydration Therapy
      • 5.5.3.1. Athletes
      • 5.5.3.2. Others
    • 5.5.4. Chemotherapy
    • 5.5.5. Enteral Nutrition
    • 5.5.6. Parenteral Nutrition
    • 5.5.7. Specialty Pharmaceuticals
    • 5.5.8. Others

Chapter 6. Home Infusion Therapy Market: Regional Market Analysis, by Product, 2017 - 2030 (USD Million)

  • 6.1. Definitions & Scope
  • 6.2. Regional Market Share Analysis, 2021 & 2030
  • 6.3. Regional Market Dashboard
  • 6.4. Regional Market Snapshot
  • 6.5. Regional Market Share, 2021
  • 6.6. Market Size, & Forecasts, and Trend Analysis, 2017 to 2030:
  • 6.7. North America
    • 6.7.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
    • 6.7.2. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
    • 6.7.3. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.7.4. U.S.
      • 6.7.4.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.7.4.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.7.5. Canada
      • 6.7.5.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.7.5.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
  • 6.8. Europe
    • 6.8.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
    • 6.8.2. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
    • 6.8.3. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.8.4. Germany
      • 6.8.4.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.8.4.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.8.5. U.K.
      • 6.8.5.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.8.5.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.8.6. France
      • 6.8.6.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.8.6.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.8.7. Italy
      • 6.8.7.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.8.7.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.8.8. Spain
      • 6.8.8.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.8.8.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.8.9. Netherlands
      • 6.8.9.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.8.9.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.8.10. Belgium
      • 6.8.10.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.8.10.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.8.11. Switzerland
      • 6.8.11.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.8.11.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.8.12. Russia
      • 6.8.12.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.8.12.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.8.13. Sweden
      • 6.8.13.1 Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.8.13.2 Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
  • 6.9. Asia Pacific
    • 6.9.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
    • 6.9.2. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
    • 6.9.3. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.9.4. China
      • 6.9.4.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.9.4.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.9.5. Japan
      • 6.9.5.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.9.5.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.9.6. India
      • 6.9.6.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.9.6.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.9.7. Australia
      • 6.9.7.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.9.7.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.9.8. South Korea
      • 6.9.8.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.9.8.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.9.9. Malaysia
      • 6.9.9.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.9.9.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.9.10. Indonesia
      • 6.9.10.1. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.9.10.2. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.9.11 Singapore
      • 6.9.11.3. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.9.11.4. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.9.12 Philippines
      • 6.9.12.5. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.9.12.6. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.9.13 Thailand
      • 6.9.13.7. Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.9.13.8. Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
  • 6.10 Latin America
    • 6.10.1 Market estimates and forecast, by country, 2017 - 2030 (USD Million)
    • 6.10.2 Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
    • 6.10.3 Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.10.4 Brazil
      • 6.10.4.1 Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.10.4.2 Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.10.5 Mexico
      • 6.10.5.1 Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.10.5.2 Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.10.6 Argentina
      • 6.10.6.1 Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.10.6.2 Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.10.7 Colombia
      • 6.10.7.1 Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.10.7.2 Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.10.8 Chile
      • 6.10.8.1 Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.10.8.2 Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
  • 6.11 Middle East and Africa
    • 6.11.1 Market estimates and forecast, by country, 2017 - 2030 (USD Million)
    • 6.11.2 Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
    • 6.11.3 Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.11.4 South Africa
      • 6.11.4.1 Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.11.4.2 Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.11.5 Saudi Arabia
      • 6.11.5.1 Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.11.5.2 Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.11.6 UAE
      • 6.11.6.1 Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.11.6.2 Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.11.7 Israel
      • 6.11.7.1 Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.11.7.2 Market estimates and forecast, by Application, 2017 - 2030 (USD Million)
    • 6.11.8 Egypt
      • 6.11.8.1 Market estimates and forecast, by Product, 2017 - 2030 (USD Million)
      • 6.11.8.2 Market estimates and forecast, by Application, 2017 - 2030 (USD Million)

Chapter 7 Home Infusion Therapy Market - Competitive Analysis

  • 7.1 Key companies profiled
    • 7.1.1 Caesarea Medical Electronics
      • 7.1.1.1 Company Overview
      • 7.1.1.2 Financial Performance
      • 7.1.1.3 Product Benchmarking
      • 7.1.1.4 Strategic Initiatives
    • 7.1.2 CareFusion Corporation
      • 7.1.2.1 Company Overview
      • 7.1.2.2 Financial Performance
      • 7.1.2.3 Product Benchmarking
      • 7.1.2.4 Strategic Initiatives
    • 7.1.3 Baxter
      • 7.1.3.1 Company Overview
      • 7.1.3.2 Financial Performance
      • 7.1.3.3 Product Benchmarking
      • 7.1.3.4 Strategic Initiatives
    • 7.1.4 B. Braun Melsungen AG
      • 7.1.4.1 Company Overview
      • 7.1.4.2 Financial Performance
      • 7.1.4.3 Product Benchmarking
      • 7.1.4.4 Strategic Initiatives
    • 7.1.5 Fresenius Kabi
      • 7.1.5.1 Company Overview
      • 7.1.5.2 Financial Performance
      • 7.1.5.3 Product Benchmarking
      • 7.1.5.4 Strategic Initiatives
    • 7.1.6 ICU Medical, Inc.
      • 7.1.6.1 Company Overview
      • 7.1.6.2 Financial Performance
      • 7.1.6.3 Product Benchmarking
      • 7.1.6.4 Strategic Initiatives
    • 7.1.7 JMS Co. Ltd.
      • 7.1.7.1 Company Overview
      • 7.1.7.2 Financial Performance
      • 7.1.7.3 Product Benchmarking
      • 7.1.7.4 Strategic Initiatives
    • 7.1.8 Smiths Medical
      • 7.1.8.1 Company Overview
      • 7.1.8.2 Financial Performance
      • 7.1.8.3 Product Benchmarking
      • 7.1.8.4 Strategic Initiatives
    • 7.1.9 Terumo Corporation
      • 7.1.9.1 Company Overview
      • 7.1.9.2 Financial Performance
      • 7.1.9.3 Product Benchmarking
      • 7.1.9.4 Strategic Initiatives